elligohealthresearch.comHealthcare / BioTech & PharmaFounded: 2016Funding to Date: $341.65MM
Elligo Health Research is a platform helping physicians and patients participate in clinical research and accelerate the development of new pharmaceuticals products.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
09/24/2021 | Series E-2 | $7.82MM | $xx.xx | $379.9MM | Ally Bridge Groupcerner, Hatteras Venture Partners, Morgan Stanley Expansion Capital, Norwest Venture Partners, Syneos Health | |
Price per Share
$xx.xx
Shares Outstanding
3,922,184
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
1000
Key Investors
Ally Bridge Groupcerner, Hatteras Venture Partners, Morgan Stanley Expansion Capital, Norwest Venture Partners, Syneos Health
|
||||||
09/24/2021 | Series E-1 | $86.92MM | $xx.xx | $379.9MM | Ally Bridge Groupcerner, Hatteras Venture Partners, Morgan Stanley Expansion Capital, Norwest Venture Partners, Syneos Health | |
Price per Share
$xx.xx
Shares Outstanding
68,185,237
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
1000
Key Investors
Ally Bridge Groupcerner, Hatteras Venture Partners, Morgan Stanley Expansion Capital, Norwest Venture Partners, Syneos Health
|
||||||
12/08/2020 | Series D | $37.2MM | $xx.xx | $144.85MM | Cerner | |
Price per Share
$xx.xx
Shares Outstanding
29,181,937
Liquidation Pref Order
2
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
1000
Key Investors
Cerner
|
||||||
05/07/2019 | Series C | $18.75MM | $xx.xx | $56.08MM | Excelerate Health Ventures, Fs Healthcare Llc, Hatteras Venture Partners, Jaffray Merchant Banking, Noro-Moseley Partners, Shumway Capital | |
Price per Share
$xx.xx
Shares Outstanding
28,159,537
Liquidation Pref Order
3
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
1000
Key Investors
Excelerate Health Ventures, Fs Healthcare Llc, Hatteras Venture Partners, Jaffray Merchant Banking, Noro-Moseley Partners, Shumway Capital
|
||||||
03/20/2018 | Series B | $15.37MM | $xx.xx | $30.69MM | Excelerate Health Ventures, Fs Healthcare Llc, Hatteras Venture Partners, Noro-Moseley Partners | |
Price per Share
$xx.xx
Shares Outstanding
28,082,010
Liquidation Pref Order
4
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
1000
Key Investors
Excelerate Health Ventures, Fs Healthcare Llc, Hatteras Venture Partners, Noro-Moseley Partners
|
||||||
03/11/2016 | Series A | $4.76MM | $xx.xx | $11.76MM | Shumway Capital | |
Price per Share
$xx.xx
Shares Outstanding
11,156,224
Liquidation Pref Order
5
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Cumulative
Participating
Non-participating
Participation Cap
1000
Key Investors
Shumway Capital
|